CRISPR Therapeutics AG vs UnitedHealth Group Incorporated — Stock Comparison

CRSP
CRISPR Therapeutics AG
$51.63
▼ 1.36%
vs
UNH
UnitedHealth Group Incorporated
$368.78
▼ 0.46%
Q·Score Winner
UnitedHealth Group Incorporated
UNH6.3/10vs 5.2/10

Q·Score Breakdown

5.2
Bearish
Overall
6.3
Neutral
1.6
Quality
6.2
8.7
Health
5.3
3.5
Growth
5.1
6.8
Valuation
7.3
6.9
Sentiment
8.1
CRSP

Clean balance sheet with low leverage (0.1× debt-to-equity).

low return on equity (-30%).

UNH

82% of 28 covering analysts have a positive rating.

limited growth momentum.

Analyst Consensus

BUY
Target $83.35 (+61.4%)
23 analysts
BUY
Target $387.27 (+5.0%)
26 analysts

Fundamentals

CRSP
UNH
Trailing P/E
27.9×
-12.9×
Forward P/E
17.8×
0.0%
Profit Margin
2.7%
0.0%
Gross Margin
18.8%
-30.2%
ROE
12.2%
-97.6%
Revenue Growth
2.0%
Earnings Growth
0.7%
1.79
Beta
0.41
Price / Book
$5.0B
Market Cap
$334.9B
$33 – $78
52-Week Range
$235 – $410

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →